Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 11, Issue 1, 2007, Pages 77-84

  Liu, Hsiu Chih ^a,b   Wang, Hsiao Chien ^b   Ko, Shun Yao ^b   Wang, Pei Ning ^a,b   Chi, Chin Wen ^a,b   Hong, Chen Jee ^a,b   Lin, Ker Neng ^b,c   Liu, Tsung Yun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Amyloid protein precursor (A PP); And Mini Mental State Examination (MMSE); A PP isoform ratio; Platelet

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DETERIORATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; STATISTICAL SIGNIFICANCE; THROMBOCYTE;

EID: 33847755898     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-11111     Document Type: Article

References (27)

1. F. Baskin, R.N. Rosenberg, L. Iyer, L. Hynan and C.M. Cullum, Platelet APP isoform ratios correlate with declining cognition in AD, Neurology 54 (2000), 1907-1909.
2. F. Baskin, R.N. Rosenberg, X. Fang, L.S. Hynan, C.B. Moore, M. Weiner and G.L. Vega, Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients, Neurology 60 (2003), 2006-2007.
3. B. Borroni, F. Colciaghi, P. Corsini, N. Akkawi, L. Rozzini, E. Del Zotto, G. Talarico, F. Cattabeni, G.L. Lenzi, M. Di Luca and A. Padovani, Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms, Neuro Sci 23 (2002), 207-210.
4. B. Borroni, F. Colciaghi, L. Pastorino, C. Pettenati, E. Cottini, L. Rozzini, R. Monastero, G. L. Lenzi, F. Cattabeni, M. Di Luca and A. Padovani, Amyloid precursor protein in platelets of patients with Alzheimer disease. Effect of acetylcholinesterase inhibitor treatment, Arch Neurol 58 (2001), 442-446.
5. B. Borroni, F. Colciaghi, L. Pastorino, S. Archetti, P. Corsini, F. Cattabeni, M. Di Luca and A. Padovani, ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model, Eur Neuropsychopharmacol 12 (2002), 195-200.
6. B. Borroni, F. Colciaghi, S. Archetti, E. Marcello, L. Caimi, M. Di Luca and A. Padovani, Predicting cognitive decline in Alzheimer disease. Role of platelet amyloid precursor protein, Alzheimer Dis Assoc Disord 18 (2004), 32-34.
7. A.L. Bush, R.N. Martins, B. Rumble, R. Moir, S. Fuller, E. Milward, J. Currie, D. Ames, A. Weidemann, P. Fischer, G. Multhaup, K. Beyreuther and C.L. Masters, The amyloid precursor protein of Alzheimer's disease is released by human platelets, J Biol Chem 265 (1990), 5977-5983.
8. A.I. Bush and R.E. Tanzi, Alzheimer disease - related abnormalities of amyloid β precursor protein isoforms in the platelet. The brain's delegate in the periphery? Arch Neurol 55 (1998), 179-180.
9. F. Cattabeni, F. Colciaghi and M. Di Luca, Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease, Prog Neuropsychopharmacol Biol Psychiatry 28 (2004), 763-770.
10. D.P. Devanand, M. Folz, M. Gorlyn, J.R. Moeller and Y. Stern, Questionable dementia: clinical course and predictors of outcome, J Am Geriatr Soc 45 (1997), 321-328.
11. M. Di Luca, L. Pastorino, F. Cattabeni, R. Zanardi, S. Scarone, G. Racagni, E. Smeraldi and J. Perez, Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome, Arch Neurol 53 (1996), 1162-1166.
12. M. Di Luca, L. Pastorino, A. Bianchetti, J. Perez, L.A. Vignolo, G.L. Lenzi, M. Trabucchi, F. Cattabeni and A. Padovani, Differential level of platelet amyloid β precursor protein isoforms. An early marker for Alzheimer disease, Arch Neurol 55 (1998), 1195-1200.
13. M. Di Luca, F. Colciaghi, L. Pastorino, B. Borroni, A. Padovani and F. Cattabeni, Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein, Eur J Pharmacol 405 (2000), 277-283.
14. M.F. Folstein, S.E. Folstein and P.R. McHugh, Mini-mental state. A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 12 (1975), 189-198.
15. C.P. Hughes, L. Berg, W.L. Danziger, L.A. Coben and R.L. Martin, A new clinical scale for the staging of dementia, Br J Psychiatry 140 (1982), 566-572.
16. Q.X. Li, M.C. Berndt, A.I. Bush, B. Rumble, I. Mackenzie, A. Friedhuber, K. Beyreuther and C.L. Masters, Membraneassociated forms of the βA4 amyloid protein precursor of Alzheimer's disease in human platelet and brain: surface expression on the activated human platelet, Blood 84 (1994), 133-142.
17. K.N. Lin, P.N. Wang, C.Y. Liu, W.T. Chen, Y.C. Lee and H.C. Liu, Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia, Dement Geriatr Cogn Disord 14 (2002), 176-182.
18. H.C. Liu, C.W. Chi, S.Y. Ko, H.C. Wang, C.J. Hong, K.N. Lin, P.N. Wang and T.Y. Liu, Cholinesterase inhibitor affects the amyloid precursor protein isoforms in patients with Alzheimer's disease, Dement Geriatr Cogn Disord 19 (2005), 345-348.
19. G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the aus pices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
20. J.C. Morris, The clinical dementia rating (CDR): current version and scoring rules, Neurology 43 (1993), 2412-2414.
21. A. Padovani, B. Borroni, F. Colciaghi, L. Pastorino, S. Archetti, E. Cottini, L. Caimi, F. Cattabeni and M. Di Luca, Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target, Mech Ageing Dev 122 (2001), 1997-2004.
22. A. Pavovani, L. Pastorino, B. Borroni, F. Colciaghi, L. Rozzini, R. Monastero, J. Perez, C. Pettenati, M. Mussi, G. Parrinello, E. Cottini, G.L. Lenzi, M. Trabucchi, F. Cattabeni and M. Di Luca, Amyloid precursor protein in platelets. A peripheral marker for the diagnosis of sporadic AD, Neurology 57 (2001), 2243-2248.
23. A. Padovani, B. Borroni, F. Colciaghi, C. Pettenati, E. Cottini, C. Agosti, C.L. Lenzi, C. Caltagirone, M. Trabucchi, F. Cattabeni and M. Di Luca, Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease, Arch Neurol 59 (2002), 71-75.
24. R.N. Rosenberg, F. Baskin, J.A. Fosmire, R. Risser, P. Adams, D. Svetlik, L.S. Honig, C.M. Cullum and M.F. Weiner, Altered amyloid protein processing in platelets of patients with Alzheimer disease, Arch Neurol 54 (1997), 139-144.
25. V. Solfrizzi, A. D'Introno, A.M. Colacicco, C. Capurso, O. Todarello, V. Pellicani, S.A. Capurso, G. Pietrarossa, V. Santamato, A. Capurso and F. Panza, Circulating biomarkers of cognitive decline and dementia, Clin Chim Acta (2005), (online at www.sciencedirect.com).
26. E.L. Teng, K. Hasegawa, A. Homma, Y. Imai, E. Larson, A. Graves, K. Sugimoto, T. Yamaguchi, H. Sasaki, D. Chiu and L.R. White, The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia, Int Psychogeriatr 6 (1994), 45-58.
27. S. Whyte, N. Wilson, J. Currie, P. Maruff, V. Malone, R. Shafig-Antonacci, P. Tyler, K.L. Derry, J. Underwood, O.X. Li, K. Beyreuther and C.L. Masters, Collection and normal levels of the amyloid precursor protein in plasma, Ann Neurol 41 (1997), 121-124.